Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Novel pressure relieving and sensing mattress and an intelligent control system that predicts and prevents pressure ulcers in bedridden patients

Objective

ReQbo is developing a disruptive system for preventing pressure ulcers (PU) in bedridden patients by intelligently and
continuously assessing a personalized risk score for each patient. This system is the first market solution offering active
preventive care, instead of the reactive care that is enabled by competing technologies. Accordingly, the system will be
capable of contributing to a steep reduction in PU incidence in long-term care units, both in hospitals and nursing homes.
Treating pressure ulcers is very costly, accounting for more than €20 billion per year supported by EU public healthcare
systems. Prevention and early detection are the main priorities to reduce this current healthcare burden. Despite
improvements in healthcare systems and technologies, patients are still at risk of developing pressure ulcers, because of
ineffective and incomplete routine care to assign preventive measures. With current technologies and clinical practices,
patients in need of prevention cannot be accurately and reliably detected, which lead to PU development. While the
treatments options are well established once a patient has been diagnosed with high PU-risk, the method for assessing that
risk has not evolved significantly in 20 years.
In order to tackle this challenge, ReQbo has developed and patented its Qone system: a pressure relieving mattress, with
integrated temperature and pressure mapping sensors, that synchronizes data with a highly accurate screening algorithm.
This algorithm assesses a PU risk score based on individual patient parameters and a long-term record of how pressure and
temperature have been distributed in the patient’s body, allowing a reduction of approximately 75% on the overall number of
new pressure ulcers in bedridden patients. The result of each risk score assessment is communicated wirelessly to the
accompanying app and to the hospital monitoring system in order to inform the caretaker that a preventive measure needs to
be implemented.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-SMEInst-2016-2017

See all projects funded under this call

Coordinator

REQBO APS
Net EU contribution
€ 50 000,00
Address
PALLE JUUL-JENSENS BOULEVARD 82
8200 AARHUS N
Denmark
SME
Yes
Region
Danmark Midtjylland Østjylland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 71 429,00